Comparison of Carbetocin with Oxytocin in preventing postpartum hemorrhage after normal vaginal delivery
Phase 3
- Conditions
- Health Condition 1: O720- Third-stage hemorrhage
- Registration Number
- CTRI/2023/07/055317
- Lead Sponsor
- ivya Mercy Anil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All nulliparous singleton cephalic pregnancies who have completed 37weeks of gestation and induced for labour
Exclusion Criteria
All antepartum hemorrhage,pregnancy complications like hypertensive disorders, gestational diabetes,premature rupture of membranes,hypersensitivity to active substances in drug,known bleeding or coagulation disorders,operative delivery,uterine overdistension(suspected macrosomia,polyhydraminos),intrapartum fever.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is bloodloss upto 500ml within 24hours of delivery <br/ ><br>Pulse rate,Blood Pressure,Hemoglobin on postnatal day 3,use of any additional uterotonics,need for any surgical interventionsTimepoint: Within 24hours of delivery
- Secondary Outcome Measures
Name Time Method Blood loss more than 500ml after delivery,need for additional uterotonic agents,blood transfusion,surgical intervention,Hemoglobin fall,any adverse drug effects like flushing,vomiting,abdominal pain,dizziness,shivering & headacheTimepoint: 72hours postpartum